GRAIL Inc. Common Stock (GRALV)
NASDAQ: GRALV
· Real-Time Price · USD
18.63
1.41 (8.19%)
At close: Jun 24, 2024, 8:00 PM
Company Description
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection.
The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.
It is also developing minimal residual disease and other post-diagnostic tests.
GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016.
The company was incorporated in 2015 and is based in Menlo Park, California.
GRAIL, LLC operates as a subsidiary of Illumina, Inc.
GRAIL Inc. Common Stock
| Country | United States |
| IPO Date | n/a |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Robert P. Ragusa |
Contact Details
Address: 1525 O’Brien Drive Menlo Park, California United States | |
| Website | https://grail.com |
Stock Details
| Ticker Symbol | GRALV |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Robert P. Ragusa | Chief Executive Officer |
| Aaron Freidin | Chief Financial Officer |
| Julie Currie | Chief People Officer |
| Abram Barth J.D., M.P.H. | General Counsel |
| Amoolya Singh Ph.D. | Senior Vice President of Research & Chief Scientific Officer |
| Dr. Joshua J. Ofman M.D., M.S.H.S | President |
| Gautam K. Kollu | Chief Commercial Officer |
| Paul Ciccolella | Senior Vice President of Global Development & Operations |
| Rodger Currie | Vice President and Head of Government Affairs & Alliance Development |
| Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng | President Biopharma Business & Europe |